Clipping of news on Brazilian Culture, Law and Citizenship
13/07/2015
This article was translated by an automatic translation system, and was therefore not reviewed by people.
transparent image
Anvisa determined the suspension, distribution, sale and use of lots 3225124, 3225133 - valid until October 2015 - and Lot 3225246 - valid until June 2016 - the drug Cephalexin 500mg generic tablets manufactured by Laboratorio Teuto Brasileiro S / A .
The decision came after the Fiscal Analysis Report, issued by the Instituto Adolfo Lutz, confirm the unsatisfactory results in the initial analysis of the aspect of testing and sample description for the above lots. With the decision, the company should promote the collection of existing stock on the market.
The measure is in Resolution 1,957 / 2015 published on Monday (10/7) in the Official Gazette (DOU).
Source: Anvisa
To access the Anvisa site, click here.
Our news are taken in full of our partner sites. For this reason, we can not change their content even in cases of typographical errors.
This article was translated by an automatic translation system, and was therefore not reviewed by people.